Nonspecific inhibitory activity of soluble human colon carcinoma extracts: tentative mechanism of action.
Soluble human colon carcinoma extract(s) (SCE) were potent nonspecific inhibitors of lymphoproliferative responses to mitogens. Inhibition was concomitant with induction in about 35% of cells of morphologic alterations for most of them comparable with the ones observed in mitogen-induced blast cells. Nonetheless, these blastlike cells did not proliferate. SCE did not interfere with mitogen binding to cell receptors. Moreover, SCE was unable to induce or activate suppressor cells, and its primary target cell was the unresponsive lymphoid cell itself. The inhibitory effect of SCE was early and irreversible. The differential activity of SCE can be correlated with an early [3H]uridine uptake, which was inhibited 6 hours later, as seen for the other biochemical parameters of cell activation. Also, SCE altered membrane-bound ATPase activities. Na,K-ATPase was strongly inhibited, whereas Ca2+-dependent and Mg2+-dependent ATPases were stimulated. These observations were discussed as an SCE-lymphocyte plasma membrane interaction translated into differential signals to the intracellular metabolic pathways.
D000818:Animals; D002277:Carcinoma / Q000276:immunology*; D002462:Cell Membrane / Q000201:enzymology; D002470:Cell Survival; D002478:Cells, Cultured; D003110:Colonic Neoplasms / Q000276:immunology*; D006801:Humans; D007108:Immune Tolerance; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology*; D051379:Mice; D011975:Receptors, Mitogen / Q000378:metabolism; D050378:T-Lymphocytes, Regulatory / Q000276:immunology; D013997:Time Factors
D011975:Receptors, Mitogen